News that Pfizer pulled its promising new cholesterol drug came as a disappointment to millions of Americans at risk for heart disease. However, researchers still hope to find a drug that fights bad cholesterol and improves good cholesterol. Guests talk about these new drugs and look at what's next in treating heart disease.
Joanne Silberner, NPR Science Desk reporter
Steve Nissen, Chairman of Cardiovascular Medicine at the Cleveland Clinic; Lead investigator of an earlier torcetrapib clinical trial
Snigdha Prakash, NPR reporter, covering the pharmaceutical industry